Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$573M |
| 2 |
Microsoft
MSFT
|
+$529M |
| 3 |
McDonald's
MCD
|
+$469M |
| 4 |
Walt Disney
DIS
|
+$303M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$291M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$482M |
| 2 |
Comcast
CMCSA
|
+$481M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$381M |
| 4 |
Sherwin-Williams
SHW
|
+$374M |
| 5 |
CELG
Celgene Corp
CELG
|
+$341M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.22% |
| 2 | Technology | 7.41% |
| 3 | Consumer Discretionary | 6.04% |
| 4 | Financials | 5.89% |
| 5 | Industrials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
WMC
6526
CALL
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $148K | ﹤0.01% |
1,510
+490
| +48% | +$49.5K |
2016 Q4
1 quarter
|
|
|
AHT
6527
CALL
Ashford Hospitality Trust
AHT
$14.6M
| $147K | ﹤0.01% |
+23
| New | +$161K |
2017 Q1
0 quarters
|
|
6528
CALL
Alto Ingredients
ALTO
$294M
| $147K | ﹤0.01% |
21,500
-3,600
| -14% | -$27.4K |
2013 Q4
13 quarters
|
|
6529
PUT
Rayonier Advanced Materials
RYAM
$469M
| $147K | ﹤0.01% |
10,900
-700
| -6% | -$9.83K |
2014 Q3
10 quarters
|
|
6530
Vericel Corp
VCEL
$2.1B
| $147K | ﹤0.01% |
52,414
+3,455
| +7% | +$9.76K |
2016 Q4
1 quarter
|
|
|
SMRT
6531
DELISTED
Stein Mart Inc
SMRT
| $147K | ﹤0.01% |
48,975
+21,097
| +76% | +$74.7K |
2013 Q2
15 quarters
|
|
6532
Harmony Gold Mining
HMY
$10.8B
| $146K | ﹤0.01% |
59,779
+11,246
| +23% | +$28.1K |
2016 Q3
2 quarters
|
|
|
MDRX
6533
PUT
DELISTED
Veradigm Inc. Common Stock
MDRX
| $146K | ﹤0.01% |
+11,500
| New | +$136K |
2017 Q1
0 quarters
|
|
|
RST
6534
PUT
DELISTED
ROSETTA STONE INC
RST
| $146K | ﹤0.01% |
+15,000
| New | +$126K |
2017 Q1
0 quarters
|
|
|
TTPH
6535
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $146K | ﹤0.01% |
796
+125
| +19% | +$14K |
2016 Q3
2 quarters
|
|
|
FOMX
6536
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $146K | ﹤0.01% |
29,506
+12,645
| +75% | +$122K |
2016 Q4
1 quarter
|
|
|
AAC
6537
DELISTED
AAC Holdings
AAC
| $145K | ﹤0.01% |
+16,951
| New | +$139K |
2017 Q1
0 quarters
|
|
|
FNFV
6538
DELISTED
Fidelity Natl Financial, Inc.
FNFV
| $145K | ﹤0.01% |
+10,945
| New | +$138K |
2017 Q1
0 quarters
|
|
6539
CALL
Star Bulk Carriers
SBLK
$3.58B
| $144K | ﹤0.01% |
+12,100
| New | +$109K |
2017 Q1
0 quarters
|
|
|
VRN
6540
PUT
DELISTED
Veren
VRN
| $144K | ﹤0.01% |
13,300
-1,800
| -12% | -$20.9K |
2016 Q3
2 quarters
|
|
|
GSS
6541
DELISTED
Golden Star Resources Ltd.
GSS
| $144K | ﹤0.01% |
33,938
-4,417
| -12% | -$19K |
2015 Q3
6 quarters
|
|
|
XONE
6542
CALL
DELISTED
The ExOne Company
XONE
| $144K | ﹤0.01% |
14,100
-4,900
| -26% | -$49.4K |
2013 Q3
14 quarters
|
|
|
CHU
6543
DELISTED
China Unicom (HONG KONG) Limited
CHU
| $144K | ﹤0.01% |
10,676
-9,797
| -48% | -$120K |
2016 Q4
1 quarter
|
|
6544
PUT
Babcock & Wilcox
BW
$840M
| $143K | ﹤0.01% |
+1,530
| New | +$214K |
2017 Q1
0 quarters
|
|
6545
PUT
Ocular Therapeutix
OCUL
$1.59B
| $143K | ﹤0.01% |
+15,400
| New | +$128K |
2017 Q1
0 quarters
|
|
|
GLUU
6546
PUT
DELISTED
Glu Mobile Inc.
GLUU
| $143K | ﹤0.01% |
63,000
-125,600
| -67% | -$271K |
2013 Q2
15 quarters
|
|
|
MEET
6547
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $143K | ﹤0.01% |
24,318
-36,919
| -60% | -$187K |
2015 Q4
5 quarters
|
|
6548
PUT
ProShares UltraShort Dow 30
DXD
$35.1M
| $142K | ﹤0.01% |
+555
| New | +$147K |
2017 Q1
0 quarters
|
|
|
CASC
6549
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $142K | ﹤0.01% |
+34,115
| New | +$143K |
2017 Q1
0 quarters
|
|
|
CALY
6550
PUT
Callaway Golf Company
CALY
$2.55B
| $141K | ﹤0.01% |
+12,700
| New | +$139K |
2017 Q1
0 quarters
|
|
Similar funds
Citadel Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, Citadel Advisors held 8,634 positions worth $109B, up 11% from $99B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citadel Advisors deployed $4.43B of net new capital in Q1 2017, opening 1,445 new positions and adding to 2,647 existing holdings. Its largest new stake was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, down from 63% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $482M trimmed.
- Citadel Advisors's largest Q1 2017 buy was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
- Citadel Advisors added most to Microsoft in Q1 2017, an estimated $529M increase.
- Citadel Advisors's biggest Q1 2017 reduction was Alphabet (Google) Class A, cutting an estimated $482M.
- Citadel Advisors fully exited Celgene Corp in Q1 2017, selling an estimated $341M.
- Citadel Advisors's ten largest holdings make up 19% of its $109B portfolio in Q1 2017.
- Citadel Advisors opened 1,445 new positions and closed 1,267 in Q1 2017.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $109B.
Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.